The Case of Rufomyazine and Rufomycin: Residual Complexity Does Impact Organic Chemistry and Drug Discovery

Emily Miller*

The intriguing monograph by the late Robert Shapiro noted, the question of our beginnings is a glorious one. How did we get to our modern biology, which looks to be incredibly different but uses the same basic mechanisms and building blocks practically everywhere? Such a loaded topic has undoubtedly produced a number of theories, some of which Shapiro better defines as myths because they do not hold up to scientific investigation.

Indexé dans

  • CASS
  • Google Scholar
  • Ouvrir la porte J
  • Infrastructure nationale du savoir de Chine (CNKI)
  • CiterFactor
  • Cosmos SI
  • Bibliothèque de revues électroniques
  • Répertoire d’indexation des revues de recherche (DRJI)
  • Laboratoires secrets des moteurs de recherche

Voir plus